HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenjian Lan Selected Research

Colorectal Neoplasms (Colorectal Cancer)

3/2018Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells.
10/2015Gliotoxin Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenjian Lan Research Topics

Disease

5Neoplasms (Cancer)
03/2024 - 08/2015
2Triple Negative Breast Neoplasms
03/2024 - 05/2021
2Colorectal Neoplasms (Colorectal Cancer)
03/2018 - 10/2015
1Breast Neoplasms (Breast Cancer)
03/2024
1Osteolysis
03/2024
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
07/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2021
1Glioma (Gliomas)
01/2021
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
10/2015
1Colonic Neoplasms (Colon Cancer)
08/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2015

Drug/Important Bio-Agent (IBA)

2GliotoxinIBA
03/2018 - 10/2015
1huanglianIBA
03/2024
1CytokinesIBA
03/2024
1Interleukin-8 (Interleukin 8)IBA
03/2024
1epiberberineIBA
03/2024
1Docetaxel (Taxotere)FDA Link
03/2024
1Therapeutic UsesIBA
03/2024
1hirsutanol AIBA
07/2021
1pifithrinIBA
07/2021
1Nonprescription Drugs (Patent Medicines)IBA
05/2021
1alpha-hydroxyglutarateIBA
01/2021
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021
1LuciferasesIBA
10/2015
1CateninsIBA
10/2015
1Terpenes (Terpenoids)IBA
08/2015
1Caspase 3 (Caspase-3)IBA
08/2015
1Caspase 8 (Caspase-8)IBA
08/2015
1Caspase 9IBA
08/2015
1Proteins (Proteins, Gene)FDA Link
08/2015
1methyl sartortuoateIBA
08/2015

Therapy/Procedure

1Therapeutics
05/2021